Ceftazidime
Cat.No:IC4140 Solarbio
CAS:72558-82-8
Molecular Formula:C22H22N6O7S2
Molecular Weight:546.58
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My CartCAS:72558-82-8
Molecular Formula:C22H22N6O7S2
Molecular Weight:546.58
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to yellow Solid
Qty:
Size:
CAS | 72558-82-8 |
Name | Ceftazidime |
Molecular Formula | C22H22N6O7S2 |
Molecular Weight | 546.58 |
Solubility | Soluble in Water ≥10mg/mL(Need ultrasonic or Water bath) |
Purity | ≥98% |
Appearance | White to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 276-715-9 |
MDL | MFCD00072034 |
SMILES | CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-] |
Target Point | Bacterial |
Passage | Anti-infection |
Background | Ceftazidime is a cephalosporin antibiotic with a wide range of antibacterial activity against gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also effective against Enterobacteriaceae (including beta-lactamase-positive strains) and has an anti-hydrolysis effect against most beta-lactamases. |
Unit | Bottle |
Specification | 100mg 200mg 500mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
The Mechanism of Oral Melatonin Ameliorates Intestinal and Adipose Lipid Dysmetabolism Through Reducing Escherichia Coli-Derived Lipopolysaccharide
Click to check >>Author:Rong B; Wu Q; Reiter RJ; Sun C.
IF:7.2000
Publish_to:Cell Mol Gastroenterol Hepatol
PMID:34242820
A comprehensive description of the TolC effect on the antimicrobial susceptibility profile in Enterobacter bugandensis
Click to check >>Author:Li B; Zhang J; Li X
IF:4.8310
Publish_to:Front Cell Infect Microbiol
PMID:36569193
Co-Occurrence of the blaKPC-2 and Mcr-3.3 Gene in Aeromonas caviae SCAc2001 Isolated from Patients with Diarrheal Disease
Click to check >>Author:Tang L; Huang J; She J; Zhao K; Zhou Y
IF:3.9000
Publish_to:Infect Drug Resist
PMID:32547122